9 Things to Know About Biosimilars and Interchangeable Biosimilars

by Pill Pals Customer Service | Sep 18, 2025 | News

FDA-approved biosimilars are safe and effective biologic medications that are highly similar to biologic medications already approved by FDA – called “reference products.” There are no clinically meaningful differences in safety, purity, or potency (safety and...

Neonatal Gonococcal Conjunctivitis Caused by Fluoroquinolone-Resistant Neisseria gonorrhoeae

by Pill Pals Customer Service | Sep 18, 2025 | News

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Since the introduction of prophylactic ophthalmic solutions by Carl Credé in 1881, the...

FDA updates guidance on interchangeability

by Pill Pals Customer Service | Sep 18, 2025 | News

[6/20/2024] Today, FDA issued a draft guidance for industry “Considerations for Demonstrating Interchangeability with a Reference Product: Update.”This draft guidance describes considerations regarding a switching study or studies intended to support a demonstration...

Malassezia [mal″ə-sē′zhə]

by Pill Pals Customer Service | Sep 18, 2025 | News

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Universidade Metropolitana de Santos, Santos, Brazil (F.P. Sellera);...